1,5-dihydro-3-isopropyl-8-methyl-[1,3]dioxepino[5,6-c]pyridin-9-yl acetate

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

Oct. 2000 - Febr. 2001

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: The accordance of the study with its protocol, the OECD Guideline 401 and the Principles of Good Laboratory Practice (GLP) is guaranteed.

Cross-reference

Cross-reference 1

Reason / purpose for cross-reference:

reference to same study

Cross-reference 2

Reason / purpose for cross-reference:

reference to other study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2001

Report date:

2001

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 401 (Acute Oral Toxicity)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Test type:

acute toxic class method

Limit test:

no

Test material

Test material information

Constituent 1

Reference substance name:

1,5-dihydro-3-isopropyl-8-methyl-[1,3]dioxepino[5,6-c]pyridin-9-yl acetate

EC Number:

296-417-2

EC Name:

1,5-dihydro-3-isopropyl-8-methyl-[1,3]dioxepino[5,6-c]pyridin-9-yl acetate

Cas Number:

92671-67-5

Molecular formula:

C14H19NO4

IUPAC Name:

8-methyl-3-(propan-2-yl)-1H,3H,5H-[1,3]dioxepino[5,6-c]pyridin-9-yl acetate

Details on test material:

- Substance type: Intermediate
- Physical state: solid
- Analytical purity: not stated
- Impurities (identity and concentrations): not specified
- Lot/batch No.:
- Expiration date of the lot/batch: not stated

- Stability under test conditions: stable
- Storage condition of test material: room temperature
- Other:

Test animals

Species:

rat

Strain:

Sprague-Dawley

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Gartenstr. 27, D-33178 Borchen
- Fasting period before study: food was withheld overnight before the day of administration
- Housing: the rats housed individually in Makrolon cages (800 cm^2, height 17 cm)
- Diet (e.g. ad libitum): twice, 8 g daily
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 -25 °C
- Humidity (%): 30 - 70 %
- Air changes (per hr): not stated
- Photoperiod (hrs dark / hrs light): 12 / 12


IN-LIFE DATES: 5 days

Administration / exposure

Route of administration:

other: diluted in vehicle

Vehicle:

ethanol

Details on oral exposure:

MAXIMUM DOSE VOLUME APPLIED: 2000 mg/kg

Doses:

Group I (10 rats, 5 males and 5 females) 2000 mg/kg applied
Group II (5 rats, 5 females) 1333 mg/kg applied
Group III (5 rats, 5 females) 890 mg/kg applied
Group IV (5 rats, 5 females) 590 mg/kg applied
Group V (5 rats, 5 males) 1333 mg/kg applied

No. of animals per sex per dose:

see above - doses

Control animals:

yes

Details on study design:

- Duration of observation period following administration: 14 days (or other?) 15 days
- Frequency of observations and weighing: daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight

Statistics:

not relevant

Results and discussion

Preliminary study:

no preliminary study

Effect levels

Sex:

female

Dose descriptor:

LD50

Effect level:

2 850 mg/kg bw

Mortality:

The following times of death after administration of Isobutyralacetat were recorded:
2000 mg/kg: 4 of 10
1333 mg/kg: 0 of 10
890 mg/kg: 2 of 5
590 mg/kg: 1 of 5

Clinical signs:

disturbance of coordination with hyperactivity,
lateral position, strong spasm, pain screaming, therefore euthanasia for human reasons,
ruffled fur, hard breathing, diarrhoea, severe apathy, hunched posture

Body weight:

no specific findings

Gross pathology:

The post-mortem findings did not show any macroscopic organ changes

Other findings:

no other findings

Any other information on results incl. tables

no additional remarks

Applicant's summary and conclusion

Interpretation of results:

other: categorie V GHS

Remarks:

Criteria used for interpretation of results: OECD GHS

Conclusions:

Isobutyralacetate needs not to be classified neighter according to 67/548/EEC nor 1272/2008/EEC. Category 5 has to be selected according to OECD GHS

Executive summary:

The test substance dissolved in diluted absolute ethanol was administered orally in two doses within less than 3 hours to five groups of Sprague Dawley rats:

Group I (l0 rats, 5 males and 5 females) 2000 mg/kg applied

Group II (5 rats, 5 females) 1333 mg/kg applied

Group III (5 rats, 5 females) 890 mg/kg applied

Group IV (5 rats, 5 females) 590 mglkg applied

Group V (5 rats, 5 males) 1333 mg/kg applied

Isobutyralacetat, a solid, was dissolved immediately prior to administration in pure ethanol. Therefore, Group VI demonstrates the inoffensiveness of administrating ethanol: Group VI (4 rats, 2 males and 2 females)

Acute toxicological synlptoms attributed to the exposure to Isobutyralacetat could be observed in 4

out of ten rats dosed with 2000 mg/kg, in 0 rats out of 10 dosed with 1333 mg/kg, in 2 out of 5 rats

dosed with 890 mg/kg and in 1 out of 5 rats dosed with 590 mg/kg. The post-mortem findings did

not show any macroscopic organ changes. The LD50 value of Isobutyralacetat was determined to

2824 mg/kg for the female sex according to Probit Analysis.